2325 Stock Overview
Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 2325 from our risk checks.
Yunkang Group Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$11.08 |
52 Week High | HK$14.88 |
52 Week Low | HK$10.86 |
Beta | 0 |
1 Month Change | -2.64% |
3 Month Change | -2.81% |
1 Year Change | -21.75% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 30.35% |
Recent News & Updates
Recent updates
Estimating The Intrinsic Value Of Yunkang Group Limited (HKG:2325)
Sep 06Why We're Not Concerned About Yunkang Group Limited's (HKG:2325) Share Price
Jul 22We Think You Should Be Aware Of Some Concerning Factors In Yunkang Group's (HKG:2325) Earnings
Sep 29Yunkang Group Limited (HKG:2325) Shares Could Be 37% Below Their Intrinsic Value Estimate
Aug 19Shareholder Returns
2325 | HK Healthcare | HK Market | |
---|---|---|---|
7D | -0.7% | -1.8% | 0.3% |
1Y | -21.8% | -29.8% | -12.7% |
Return vs Industry: 2325 exceeded the Hong Kong Healthcare industry which returned -29.8% over the past year.
Return vs Market: 2325 underperformed the Hong Kong Market which returned -12.7% over the past year.
Price Volatility
2325 volatility | |
---|---|
2325 Average Weekly Movement | 3.1% |
Healthcare Industry Average Movement | 6.8% |
Market Average Movement | 7.3% |
10% most volatile stocks in HK Market | 14.7% |
10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 2325 has not had significant price volatility in the past 3 months.
Volatility Over Time: 2325's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | 1,510 | Yong Zhang | https://www.yunkanghealth.com |
Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic tests, including hepatitis B virus, tuberculosis, human papilloma virus, EB virus, rabies virus, and nucleic acid tests for respiratory pathogens; genetic reproduction and screening tests; and routine diagnostic tests for chronic kidney, blood, autoimmune, endocrine metabolism, and other diseases.
Yunkang Group Limited Fundamentals Summary
2325 fundamental statistics | |
---|---|
Market cap | HK$6.88b |
Earnings (TTM) | -HK$110.71m |
Revenue (TTM) | HK$965.17m |
7.1x
P/S Ratio-62.2x
P/E RatioIs 2325 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2325 income statement (TTM) | |
---|---|
Revenue | CN¥891.50m |
Cost of Revenue | CN¥565.71m |
Gross Profit | CN¥325.79m |
Other Expenses | CN¥428.05m |
Earnings | -CN¥102.26m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.16 |
Gross Margin | 36.54% |
Net Profit Margin | -11.47% |
Debt/Equity Ratio | 63.6% |
How did 2325 perform over the long term?
See historical performance and comparisonDividends
0.2%
Current Dividend Yield-11%
Payout RatioDoes 2325 pay a reliable dividends?
See 2325 dividend history and benchmarksYunkang Group dividend dates | |
---|---|
Ex Dividend Date | Jul 04 2024 |
Dividend Pay Date | Aug 30 2024 |
Days until Ex dividend | 98 days |
Days until Dividend pay date | 155 days |
Does 2325 pay a reliable dividends?
See 2325 dividend history and benchmarks